Repare Therapeutics (Nasdaq: RPTX) is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highl...